Cipla receives final approval for generic version of Proventil

Cipla Limited announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation, from the United States Food and Drug Administration (US FDA).

source https://www.pharmatutor.org/pharma-news/2020/cipla-receives-final-approval-for-generic-version-of-proventil